NATIONAL CANCER INSTITUTE BRIEFING ON "THERAPEUTIC STUDIES OF PRIMARYCENTRAL NERVOUS SYSTEM MALIGNANCIES IN ADULTS"



NIH GUIDE, Volume 21, Number 44, December 11, 1992



P.T. 34



Keywords:

  Cancer/Carcinogenesis 

  Nervous System 

  Biological Response Modifiers 

  Chemotherapeutic Agents 



National Cancer Institute



Request for Applications (RFA) CA-93-03, for cooperative agreements

(U01) from consortia of institutions to perform Phase I and II clinical

evaluations of promising new chemotherapeutic or biologic agents for

the treatment of primary central nervous system (CNS) malignancies was

published in the NIH Guide for Grants and Contracts, Vol. 21, No. 41,

November 13, 1992.



The National Cancer Institute (NCI) will hold a briefing session

concerning this RFA on Tuesday, January 19, 1993 in Conference Room H,

Executive Plaza North, 6130 Executive Boulevard, Rockville, MD to

discuss this initiative and answer questions.  Two sessions will be

held from 9:00 a.m. to 11:00 a.m. and 2:00 p.m. to 4:00 p.m.  Potential

applicants may attend either session.  All interested parties are

invited to attend.



INQUIRIES



For further information and to register for the meeting, contact:



Ms. Diane Bronzert

Cancer Therapy Evaluations Program

Division of Cancer Treatment

National Cancer Institute

Executive Plaza North, Room 734

Bethesda, MD  20892

Telephone:  (301) 496-8866

FAX:  (301) 480-4663



.

Return to 1992 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER) 		  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892 		  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) 		  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.